Glickman Mark A

Co-Chief Executive Officer at TXMD; Chief Commercial Officer at Aralez Pharmaceuticals Inc.; EVP - Sales and Marketing at AUXILIUM PHARMACEUTICALS INC

Sold, on record
$1.6M
Dollars the filings state
Form 4 sales
3
Latest Dec 6, 2022
Form 144 notices
0
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale AUXILIUM PHARMACEUTICALS INCUnusual
    Nov 20, 2014 2014

    Sold 47,952 shares at $33.16 ($1.6M)

    Glickman Mark A, EVP - Sales and Marketing

    Sold 63.2% of holdings ($2.5M position)27,911 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale Aralez Pharmaceuticals Inc.Plan not stated
    Mar 19, 2018 +1215 days

    Sold 5,725 shares at $1.70 ($10k)

    Glickman Mark A, Chief Commercial Officer

    Sold 2.2% of holdings ($435k position)250,188 shares leftFirst sale on recordFiling

  3. 3 Form 4 sale TXMDUnusual
    Dec 6, 2022 +1723 days

    Sold 440 shares at $4.92 ($2k)

    Glickman Mark A, Co-Chief Executive Officer

    Sold 25.4% of holdings ($9k position)1,294 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Glickman Mark A
Source
Dec 6, 2022Dec 9, 2022TXMDCo-Chief Executive OfficerForm 4 sale440$2k25.4%UnusualSEC
Mar 19, 2018Mar 21, 2018Aralez Pharmaceuticals Inc.Chief Commercial OfficerForm 4 sale5,725$10k2.2%Plan not statedSEC
Nov 20, 2014Nov 24, 2014AUXILIUM PHARMACEUTICALS INCEVP - Sales and MarketingForm 4 sale47,952$1.6M63.2%UnusualSEC